Orzel New Zealand - engelsk - Medsafe (Medicines Safety Authority)

orzel

pharmacy retailing (nz) ltd t/a healthcare logistics - tegafur 100mg; uracil 224mg; calcium folinate 16.2mg equivalent to 15 mg folinate - combination - active: tegafur 100mg uracil 224mg excipient: gelatin hyprolose as low-substituted hydroxypropoyl cellulose sodium laurilsulfate titanium dioxide active: calcium folinate 16.2mg equivalent to 15 mg folinate excipient: iron oxide red lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate starch

UFT New Zealand - engelsk - Medsafe (Medicines Safety Authority)

uft

pharmacy retailing (nz) ltd t/a healthcare logistics - tegafur 100mg; uracil 224mg - combination capsule - active: tegafur 100mg uracil 224mg excipient: gelatin hyprolose as low-substituted hydroxypropyl cellulose sodium laurilsulfate titanium dioxide

UFT Capsules Hard 100/224 Milligram Irland - engelsk - HPRA (Health Products Regulatory Authority)

uft capsules hard 100/224 milligram

merck serono limited - tegafur uracil - capsules hard - 100/224 milligram

CAPECITABINE TEVA  150 MG Israel - engelsk - Ministry of Health

capecitabine teva 150 mg

abic marketing ltd, israel - capecitabine - film coated tablets - capecitabine 150 mg - capecitabine - adjuvant colon cancer: capecitabine teva® is indicated for the adjuvant treatment of patients following surgery of stage iii (dukesע stage c) colon cancer. colorectal cancer: capecitabine teva® is indicated for the treatment of patients with advanced or metastatic colorectal cancer. advanced gastric cancer: capecitabine teva® is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy. breast cancer combination therapy: capecitabine teva® in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. breast cancer monotherapy: capecitabine teva® is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.